サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1661158

等温核酸増幅技術の市場規模、シェア、動向、予測：製品別、技術別、用途別、エンドユーザー別、地域別、2025年～2033年

Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
等温核酸増幅技術の市場規模、シェア、動向、予測：製品別、技術別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

等温核酸増幅技術の市場の世界市場規模は2024年に34億米ドルとなった。今後、IMARC Groupは、2033年までに市場は82億米ドルに達し、2025年から2033年にかけて10.3％のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは43.4%を超えています。迅速で正確な診断に対する需要の高まり、感染症の流行、ポータブル検査機器の急速な進歩、ヘルスケア、食品安全、環境モニタリングなどのアプリケーションの拡大、政府の強力な支援などが、等温核酸増幅技術の市場シェアを押し上げる主な要因です。

等温核酸増幅技術（INAAT）は、分子生物学や組み換えDNA技術において、核酸の検出や同定に使用されます。一定の温度で核酸を増幅するため、サーモサイクラーを必要としないです。主にRNA、DNA、細胞、タンパク質、低分子、イオンに利用され、遺伝性疾患、遺伝性疾患、感染性疾患を迅速、高感度、正確に診断することができます。多用途の核酸ナノ材料の製造に使用されるアンプリコンを生成します。これに加えて、（HIV）、結核、インフルエンザ、A型肝炎、B型肝炎、クラミジア、淋病（CT/NG）など、さまざまな感染症の検出にも役立っています。その結果、INAATは世界中で絶大な支持を得ています。

世界の等温核酸増幅技術の市場動向：

コロナウイルス感染症（COVID-19）を検出するINAATの開発が進んでいることは、市場にプラスの影響を与えている主要因の1つです。これに伴い、世界の老年人口の増加、がんやその他の慢性疾患の有病率の上昇、効率的な診断や治療法に対する需要の高まりが市場成長に寄与しています。これとは別に、DNAやRNAを増幅するためのループ媒介等温増幅（LAMP）検査の採用や遺伝子組み換え生物（GMO）の同定が、INAATの需要を刺激しています。さらに、鎖置換増幅法（SDA）、シングルプライマー等温増幅法（SPIA）、組換えポリメラーゼ増幅法（RPA）の開発が、もう一つの成長促進要因として作用しています。さらに、新興国市場の大手企業による研究開発（R&D）活動への投資の増加が市場を牽引すると予測されています。

本レポートで扱う主な質問

  • 等温核酸増幅技術の市場の市場規模は？
  • 等温核酸増幅技術の市場の将来展望は？
  • 等温核酸増幅技術の市場を牽引する主な要因は何か？
  • 等温核酸増幅技術の市場のシェアが最も高い地域はどこか？
  • 世界の等温核酸増幅技術の市場の主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の等温核酸増幅技術市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 機器
  • 試薬

第7章 市場内訳：技術別

  • ヘリカーゼ依存性増幅（HDA）
  • ニッキング酵素増幅反応（NEAR）
  • ループ介在等温増幅（LAMP）
  • 鎖置換増幅（SDA）
  • 核酸配列に基づく増幅（NASBA）
  • 転写介在増幅（TMA）
  • シングルプライマー等温増幅（SPIA）
  • その他

第8章 市場内訳：用途別

  • 感染症の診断
    • 市場動向
    • 主な種類
      • 肝炎
      • CT/NG
      • HIV
      • インフルエンザ
      • その他
    • 市場予測
  • 血液検査
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院
  • 診断検査室
  • 調査室
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • bioMerieux
    • BD（Becton, Dickinson and Company）
    • Eiken Chemical Co. Ltd
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • OptiGene Limited
    • Thermo Fisher Scientific Inc.
    • Tecan Trading AG
    • Ustar Biotechnologies Ltd.
図表

List of Figures

  • Figure 1: Global: Isothermal Nucleic Acid Amplification Technology Market: Major Drivers and Challenges
  • Figure 2: Global: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Isothermal Nucleic Acid Amplification Technology (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Isothermal Nucleic Acid Amplification Technology (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Isothermal Nucleic Acid Amplification Technology (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Isothermal Nucleic Acid Amplification Technology (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Isothermal Nucleic Acid Amplification Technology (Helicase-Dependent Amplification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Isothermal Nucleic Acid Amplification Technology (Helicase-Dependent Amplification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Isothermal Nucleic Acid Amplification Technology (Nicking Enzyme Amplification Reaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Isothermal Nucleic Acid Amplification Technology (Nicking Enzyme Amplification Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Isothermal Nucleic Acid Amplification Technology (Loop-Mediated Isothermal Amplification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Isothermal Nucleic Acid Amplification Technology (Loop-Mediated Isothermal Amplification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Isothermal Nucleic Acid Amplification Technology (Strand Displacement Amplification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Isothermal Nucleic Acid Amplification Technology (Strand Displacement Amplification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Isothermal Nucleic Acid Amplification Technology (Nucleic Acid Sequence-Based Amplification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Isothermal Nucleic Acid Amplification Technology (Nucleic Acid Sequence-Based Amplification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Isothermal Nucleic Acid Amplification Technology (Transcription Mediated Amplification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Isothermal Nucleic Acid Amplification Technology (Transcription Mediated Amplification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Isothermal Nucleic Acid Amplification Technology (Single Primer Isothermal Amplification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Isothermal Nucleic Acid Amplification Technology (Single Primer Isothermal Amplification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Isothermal Nucleic Acid Amplification Technology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Isothermal Nucleic Acid Amplification Technology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Isothermal Nucleic Acid Amplification Technology (Infectious Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Isothermal Nucleic Acid Amplification Technology (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Isothermal Nucleic Acid Amplification Technology (Blood Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Isothermal Nucleic Acid Amplification Technology (Blood Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Isothermal Nucleic Acid Amplification Technology (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Isothermal Nucleic Acid Amplification Technology (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Isothermal Nucleic Acid Amplification Technology (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Isothermal Nucleic Acid Amplification Technology (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Isothermal Nucleic Acid Amplification Technology (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Isothermal Nucleic Acid Amplification Technology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Isothermal Nucleic Acid Amplification Technology (Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Isothermal Nucleic Acid Amplification Technology (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Isothermal Nucleic Acid Amplification Technology (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Isothermal Nucleic Acid Amplification Technology (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia Pacific: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia Pacific: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Global: Isothermal Nucleic Acid Amplification Technology Industry: SWOT Analysis
  • Figure 92: Global: Isothermal Nucleic Acid Amplification Technology Industry: Value Chain Analysis
  • Figure 93: Global: Isothermal Nucleic Acid Amplification Technology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Isothermal Nucleic Acid Amplification Technology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Isothermal Nucleic Acid Amplification Technology Market: Competitive Structure
  • Table 8: Global: Isothermal Nucleic Acid Amplification Technology Market: Key Players
目次
Product Code: SR112025A2205

The global isothermal nucleic acid amplification technology market size was valued at USD 3.4 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.2 Billion by 2033, exhibiting a CAGR of 10.3% during 2025-2033. North America currently dominates the market, holding a market share of over 43.4% in 2024. The rising demand for fast and accurate diagnostics, increasing prevalence of infectious diseases, rapid advancements in portable testing devices, and expanding applications across healthcare, food safety, and environmental monitoring, with strong support from government initiatives are major factors boosting the isothermal nucleic acid amplification technology market share.

The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. It is majorly utilized for RNA, DNA, cells, proteins, small molecules, and ions to ensure the rapid, sensitive and accurate diagnosis of genetic, inherited, and infectious diseases. It generates amplicons that are employed in producing versatile nucleic acid nanomaterials. Besides this, it assists in detecting various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT/NG). As a result, INAAT is gaining immense traction across the globe.

Global Isothermal Nucleic Acid Amplification Technology Market Trends:

The ongoing development in INAAT for detecting coronavirus disease (COVID-19) represents one of the key factors positively influencing the market. In line with this, the increasing geriatric population globally and the rising prevalence of cancer and other chronic medical disorders, along with the escalating demand for efficient diagnosis and treatment alternatives, are contributing to the market growth. Apart from this, the adoption of loop-mediated isothermal amplification (LAMP) tests to amplify DNA and RNA and the identification of genetically modified organisms (GMOs) is catalyzing the demand for INAAT. Furthermore, the development of strand displacement amplification (SDA), single primer isothermal amplification (SPIA), and recombinase polymerase amplification (RPA) are acting as another growth-inducing factor. Moreover, increasing investments in research and development (R&D) activities by leading market players are projected to drive the market.

Key Market Segmentation:

Breakup by Product:

  • Instruments
  • Reagents

Reagents hold the majority of the global isothermal nucleic acid amplification technology market share due to their increasing use in therapeutics.

Breakup by Technology:

  • Helicase-Dependent Amplification (HDA)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Loop-Mediated Isothermal Amplification (LAMP)
  • Strand Displacement Amplification (SDA)
  • Nucleic Acid Sequence-Based Amplification (NASBA)
  • Transcription Mediated Amplification (TMA)
  • Single Primer Isothermal Amplification (SPIA)
  • Others

TMA accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time.

Breakup by Application:

  • Infectious Disease Diagnosis
  • Hepatitis
  • CT/NG
  • HIV
  • Influenza
  • Others
  • Blood Screening
  • Others

Infectious disease diagnosis currently dominates the market due to the rising prevalence of infectious diseases across the globe.

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Others

Hospitals presently dominate the market due to the increasing number of hospitals and significant development in the healthcare industry.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market due to the shifting consumer preference for INAAT testing over traditional diagnostic procedures.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Abbott Laboratories, bioMerieux SA, Becton, Dickinson and Company, Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, and Ustar Biotechnologies Ltd.

Key Questions Answered in This Report

  • 1.How big is the isothermal nucleic acid amplification technology market?
  • 2.What is the future outlook of isothermal nucleic acid amplification technology market?
  • 3.What are the key factors driving the isothermal nucleic acid amplification technology market?
  • 4.Which region accounts for the largest isothermal nucleic acid amplification technology market share?
  • 5.Which are the leading companies in the global isothermal nucleic acid amplification technology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Isothermal Nucleic Acid Amplification Technology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of Covid-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Helicase-Dependent Amplification (HDA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Nicking Enzyme Amplification Reaction (NEAR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Loop-Mediated Isothermal Amplification (LAMP)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Strand Displacement Amplification (SDA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nucleic Acid Sequence-Based Amplification (NASBA)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcription Mediated Amplification (TMA)
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Single Primer Isothermal Amplification (SPIA)
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 Hepatitis
      • 8.1.2.2 CT/NG
      • 8.1.2.3 HIV
      • 8.1.2.4 Influenza
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Blood Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 bioMerieux
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BD (Becton, Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Eiken Chemical Co. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Hologic Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Meridian Bioscience Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 OptiGene Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Thermo Fisher Scientific Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tecan Trading AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Ustar Biotechnologies Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio